<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Investors &amp; Media - BrainStorm Cell Therapeutics </title>
<link>https://ir.brainstorm-cell.com/</link>
<description></description>
<item>
<title>BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine</title>
<link>https://ir.brainstorm-cell.com/2026-06-02-BrainStorm-Cell-Therapeutics-Announces-Publication-Calling-for-Updated-FDA-Approaches-to-ALS,-Rare-Diseases-and-Regenerative-Medicine</link>
<description></description>
<pubDate>Tue, 02 Jun 2026 09:00:00 -0400</pubDate>
<guid>https://ir.brainstorm-cell.com/2026-06-02-BrainStorm-Cell-Therapeutics-Announces-Publication-Calling-for-Updated-FDA-Approaches-to-ALS,-Rare-Diseases-and-Regenerative-Medicine</guid>
<enclosure url="https://mma.prnewswire.com/media/1166536/BrainStorm_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors</title>
<link>https://ir.brainstorm-cell.com/2026-05-28-BrainStorm-Cell-Therapeutics-Appoints-Former-FDA-Associate-Commissioner-Peter-J-Pitts-to-Board-of-Directors</link>
<description></description>
<pubDate>Thu, 28 May 2026 07:45:00 -0400</pubDate>
<guid>https://ir.brainstorm-cell.com/2026-05-28-BrainStorm-Cell-Therapeutics-Appoints-Former-FDA-Associate-Commissioner-Peter-J-Pitts-to-Board-of-Directors</guid>
<enclosure url="https://mma.prnewswire.com/media/2989676/Peter_J_Pitts.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market</title>
<link>https://ir.brainstorm-cell.com/2026-05-19-BrainStorm-Cell-Therapeutics-Announces-Aggregate-of-400,000-in-Private-Placements-Priced-at-Premium-to-Market</link>
<description></description>
<pubDate>Tue, 19 May 2026 08:00:00 -0400</pubDate>
<guid>https://ir.brainstorm-cell.com/2026-05-19-BrainStorm-Cell-Therapeutics-Announces-Aggregate-of-400,000-in-Private-Placements-Priced-at-Premium-to-Market</guid>
<enclosure url="https://mma.prnewswire.com/media/1166536/BrainStorm_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update</title>
<link>https://ir.brainstorm-cell.com/2026-05-15-BrainStorm-Cell-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update</link>
<description></description>
<pubDate>Fri, 15 May 2026 16:05:00 -0400</pubDate>
<guid>https://ir.brainstorm-cell.com/2026-05-15-BrainStorm-Cell-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update</guid>
<enclosure url="https://mma.prnewswire.com/media/1166536/BrainStorm_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update</title>
<link>https://ir.brainstorm-cell.com/2026-03-31-BrainStorm-Cell-Therapeutics-Announces-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update</link>
<description></description>
<pubDate>Tue, 31 Mar 2026 16:01:00 -0400</pubDate>
<guid>https://ir.brainstorm-cell.com/2026-03-31-BrainStorm-Cell-Therapeutics-Announces-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update</guid>
</item>
</channel>
</rss>
